MiR-223: An inflammatory oncomiR enters the cardiovascular field

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 7, 2014, Pages 1001-1009

  Taïbi, Fatiha ^a   Metzinger Le Meuth, Valérie ^a,b   Massy, Ziad A ^a,c   Metzinger, Laurent ^a,d  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Cancer; Hematopoiesis; MicroRNA; MiR 223; Muscle; Vascular disease

Indexed keywords

BIOLOGICAL MARKER; CRYOPYRIN; INTERLEUKIN 4; K RAS PROTEIN; MICRORNA; MICRORNA 223; OSTEOCLAST DIFFERENTIATION FACTOR; RNA;

ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; BLOOD VESSEL INJURY; BREAST CANCER; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; ERYTHROPOIESIS; GENE EXPRESSION; GENE LOCATION; GRANULOPOIESIS; HEART; HEMATOPOIETIC STEM CELL; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; LEUKEMIA; LIVER CELL CARCINOMA; MACROPHAGE; METABOLIC DISORDER; MOLECULAR BIOLOGY; MONOCYTE; MUSCLE DISEASE; MUSCULAR DYSTROPHY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOCLASTOGENESIS; OVARY CANCER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RHEUMATOID ARTHRITIS; STOMACH CANCER; TUMOR ASSOCIATED LEUKOCYTE;

CANCER; HEMATOPOIESIS; MICRORNA; MIR-223; MUSCLE; VASCULAR DISEASE;

ANIMALS; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; HUMANS; INFLAMMATION; MICRORNAS; NEOPLASMS;

EID: 84897437747     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.03.005     Document Type: Review

References (60)

1. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
2. Kloosterman W.P., Plasterk R.H. The diverse functions of microRNAs in animal development and disease. Dev. Cell 2006, 11:441-450.
3. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
4. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., Croce C.M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:15524-15529.
5. Naraba H., Iwai N. Assessment of the microRNA system in salt-sensitive hypertension. Hypertens. Res. 2005, 28:819-826.
6. Rodriguez A.E., Hernandez J.A., Benito R., Gutierrez N.C., Garcia J.L., Hernandez-Sanchez M., Risueno A., Sarasquete M.E., Ferminan E., Fisac R., de Coca A.G., Martin-Nunez G., de Las Heras N., Recio I., Gutierrez O., De Las Rivas J., Gonzalez M., Hernandez-Rivas J.M. Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14. PLoS One 2012, 7:e48485.
7. Johnnidis J.B., Harris M.H., Wheeler R.T., Stehling-Sun S., Lam M.H., Kirak O., Brummelkamp T.R., Fleming M.D., Camargo F.D. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451:1125-1129.
8. Chen C.Z., Li L., Lodish H.F., Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
9. Kapinas K., Delany A.M. MicroRNA biogenesis and regulation of bone remodeling. Arthritis Res. Ther. 2011, 13:220.
10. Fazi F., Rosa A., Fatica A., Gelmetti V., De Marchis M.L., Nervi C., Bozzoni I. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005, 123:819-831.
11. Zardo G., Ciolfi A., Vian L., Starnes L.M., Billi M., Racanicchi S., Maresca C., Fazi F., Travaglini L., Noguera N., Mancini M., Nanni M., Cimino G., Lo-Coco F., Grignani F., Nervi C. Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. Blood 2012, 119:4034-4046.
12. Plante I., Ple H., Landry P., Gunaratne P.H., Provost P. Modulation of microRNA activity by semi-microRNAs. Front. Genet. 2012, 3:99.
13. O'Connell R.M., Zhao J.L., Rao D.S. MicroRNA function in myeloid biology. Blood 2011, 118:2960-2969.
14. Li T., Morgan M.J., Choksi S., Zhang Y., Kim Y.S., Liu Z.G. MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat. Immunol. 2010, 11:799-805.
15. Ismail N., Wang Y., Dakhlallah D., Moldovan L., Agarwal K., Batte K., Shah P., Wisler J., Eubank T.D., Tridandapani S., Paulaitis M.E., Piper M.G., Marsh C.B. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood 2013, 121:984-995.
16. Aucher A., Rudnicka D., Davis D.M. MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation. J. Immunol. 2013, 191:6250-6260.
17. Yuan J.Y., Wang F., Yu J., Yang G.H., Liu X.L., Zhang J.W. MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells. J. Cell. Mol. Med. 2009, 13:4551-4559.
18. Sugatani T., Hruska K.A. MicroRNA-223 is a key factor in osteoclast differentiation. J. Cell. Biochem. 2007, 101:996-999.
19. Yu Y.H., Zhang L., Wu D.S., Zhang Z., Huang F.F., Zhang J., Chen X.P., Liang D.S., Zeng H., Chen F.P. MiR-223 regulates human embryonic stem cell differentiation by targeting the IGF-1R/Akt signaling pathway. PLoS One 2010, 8:e78769.
20. Eyholzer M., Schmid S., Schardt J.A., Haefliger S., Mueller B.U., Pabst T. Complexity of miR-223 regulation by CEBPA in human AML. Leuk. Res. 2010, 34:672-676.
21. Pulikkan J.A., Dengler V., Peramangalam P.S., Peer Zada A.A., Muller-Tidow C., Bohlander S.K., Tenen D.G., Behre G. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010, 115:1768-1778.
22. Yang M., Chen J., Su F., Yu B., Lin L., Liu Y., Huang J.D., Song E. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol. Cancer 2011, 10:117.
23. Li X., Zhang Y., Zhang H., Liu X., Gong T., Li M., Sun L., Ji G., Shi Y., Han Z., Han S., Nie Y., Chen X., Zhao Q., Ding J., Wu K., Daiming F. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol. Cancer Res. 2011, 9:824-833.
24. Tran Y.K., Bogler O., Gorse K.M., Wieland I., Green M.R., Newsham I.F. A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer. Cancer Res. 1999, 59:35-43.
25. Kang W., Tong J.H., Chan A.W., Lung R.W., Chau S.L., Wong Q.W., Wong N., Yu J., Cheng A.S., To K.F. Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer. PLoS One 2012, 7:e33919.
26. Li J., Guo Y., Liang X., Sun M., Wang G., De W., Wu W. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. J. Cancer Res. Clin. Oncol. 2012, 138:763-774.
27. Wong Q.W., Lung R.W., Law P.T., Lai P.B., Chan K.Y., To K.F., Wong N. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 2008, 135:257-269.
28. Laios A., O'Toole S., Flavin R., Martin C., Kelly L., Ring M., Finn S.P., Barrett C., Loda M., Gleeson N., D'Arcy T., McGuinness E., Sheils O., Sheppard B., O.L.J. Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol. Cancer 2008, 7:35.
29. Haneklaus M., Gerlic M., Kurowska-Stolarska M., Rainey A.A., Pich D., McInnes I.B., Hammerschmidt W., O'Neill L.A., Masters S.L. Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1beta production. J. Immunol. 2012, 189:3795-3799.
30. Zhuang G., Meng C., Guo X., Cheruku P.S., Shi L., Xu H., Li H., Wang G., Evans A.R., Safe S., Wu C., Zhou B. A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 2012, 125:2892-2903.
31. Wentworth J.M., Naselli G., Brown W.A., Doyle L., Phipson B., Smyth G.K., Wabitsch M., O'Brien P.E., Harrison L.C. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010, 59:1648-1656.
32. Meng Z.X., Wang G.X., Lin J.D. A microRNA circuitry links macrophage polarization to metabolic homeostasis. Circulation 2012, 125:2815-2817.
33. Zampetaki A., Kiechl S., Drozdov I., Willeit P., Mayr U., Prokopi M., Mayr A., Weger S., Oberhollenzer F., Bonora E., Shah A., Willeit J., Mayr M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res. 2010, 107:810-817.
34. Fulci V., Scappucci G., Sebastiani G.D., Giannitti C., Franceschini D., Meloni F., Colombo T., Citarella F., Barnaba V., Minisola G., Galeazzi M., Macino G. miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum. Immunol. 2010, 71:206-211.
35. Hirota K., Hashimoto M., Yoshitomi H., Tanaka S., Nomura T., Yamaguchi T., Iwakura Y., Sakaguchi N., Sakaguchi S. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J. Exp. Med. 2007, 204:41-47.
36. Li Y.T., Chen S.Y., Wang C.R., Liu M.F., Lin C.C., Jou I.M., Shiau A.L., Wu C.L. Brief report: amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223. Arthritis Rheum. 2012, 64:3240-3245.
37. Lu H., Buchan R.J., Cook S.A. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc. Res. 2010, 86:410-420.
38. Greco S., Fasanaro P., Castelvecchio S., D'Alessandra Y., Arcelli D., Di Donato M., Malavazos A., Capogrossi M.C., Menicanti L., Martelli F. MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes 2012, 61:1633-1641.
39. van Rooij E., Sutherland L.B., Thatcher J.E., DiMaio J.M., Naseem R.H., Marshall W.S., Hill J.A., Olson E.N. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13027-13032.
40. De Rosa S., Fichtlscherer S., Lehmann R., Assmus B., Dimmeler S., Zeiher A.M. Transcoronary concentration gradients of circulating microRNAs. Circulation 2011, 124:1936-1944.
41. Song L., Duan P., Guo P., Li D., Li S., Xu Y., Zhou Q. Downregulation of miR-223 and miR-153 mediates mechanical stretch-stimulated proliferation of venous smooth muscle cells via activation of the insulin-like growth factor-1 receptor. Arch. Biochem. Biophys. 2012, 528:204-211.
42. Kin K., Miyagawa S., Fukushima S., Shirakawa Y., Torikai K., Shimamura K., Daimon T., Kawahara Y., Kuratani T., Sawa Y. Tissue- and plasma-specific microRNA signatures for atherosclerotic abdominal aortic aneurysm. J. Am. Heart Assoc. 2012, 1:e000745.
43. Rangrez A.Y., M'Baya-Moutoula E., Metzinger-Le Meuth V., Henaut L., Djelouat M.S., Benchitrit J., Massy Z.A., Metzinger L. Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223. PLoS One 2012, 7:e47807.
44. Abedin M., Tintut Y., Demer L.L. Vascular calcification: mechanisms and clinical ramifications. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1161-1170.
45. Taibi F., Meuth V.M., M'Baya-Moutoula E., El Islam Djelouat M.S., Louvet L., Bugnicourt J.M., Poirot S., Bengrine A., Chillon J.M., Massy Z.A., Metzinger L. Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease. Biochim. Biophys. Acta 2014, 1842:88-89.
46. Harris T.A., Yamakuchi M., Ferlito M., Mendell J.T., Lowenstein C.J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:1516-1521.
47. Shi L., Fisslthaler B., Zippel N., Fromel T., Hu J., Elgheznawy A., Heide H., Popp R., Fleming I. MicroRNAs-223 antagonises angiogenesis by targeting beta1 integrin and preventing growth factor signaling in endothelial cells. Circ. Res. 2013, 113:1320-1330.
48. Massy Z.A., Mentaverri R., Mozar A., Brazier M., Kamel S. The pathophysiology of vascular calcification: are osteoclast-like cells the missing link?. Diabetes Metab. 2008, 34(Suppl. 1):S16-S20.
49. Bourgoin F., Bachelard H., Badeau M., Lariviere R., Nadeau A., Pitre M. Effects of tempol on endothelial and vascular dysfunctions and insulin resistance induced by a high-fat high-sucrose diet in the rat. Can. J. Physiol. Pharmacol. 2013, 91:547-561.
50. Bao H., Chen H., Zhu X., Zhang M., Yao G., Yu Y., Qin W., Zeng C., Zen K., Liu Z. MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin alpha4 and alpha5 in IgA nephropathy. Kidney Int. 2014, 85:624-635.
51. Meyer J.M., Graf G.A., van der Westhuyzen D.R. New developments in selective cholesteryl ester uptake. Curr. Opin. Lipidol. 2013, 24:386-392.
52. Greco S., De Simone M., Colussi C., Zaccagnini G., Fasanaro P., Pescatori M., Cardani R., Perbellini R., Isaia E., Sale P., Meola G., Capogrossi M.C., Gaetano C., Martelli F. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J. 2009, 23:3335-3346.
53. Chen Y., Melton D.W., Gelfond J.A., McManus L.M., Shireman P.K. MiR-351 transiently increases during muscle regeneration and promotes progenitor cell proliferation and survival upon differentiation. Physiol. Genomics 2012, 44:1042-1051.
54. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B., Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10513-10518.
55. Hunter M.P., Ismail N., Zhang X., Aguda B.D., Lee E.J., Yu L., Xiao T., Schafer J., Lee M.L., Schmittgen T.D., Nana-Sinkam S.P., Jarjoura D., Marsh C.B. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008, 3:e3694.
56. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., Mitchell P.S., Bennett C.F., Pogosova-Agadjanyan E.L., Stirewalt D.L., Tait J.F., Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:5003-5008.
57. Mo M.H., Chen L., Fu Y., Wang W., Fu S.W. Cell-free circulating miRNA biomarkers in cancer. J. Cancer 2012, 3:432-448.
58. Menendez P., Villarejo P., Padilla D., Menendez J.M., Montes J.A. Diagnostic and prognostic significance of serum microRNAs in colorectal cancer. J. Surg. Oncol. 2013, 107:217-220.
59. Fichtlscherer S., De Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., Weber M., Hamm C.W., Roxe T., Muller-Ardogan M., Bonauer A., Zeiher A.M., Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 2010, 107:677-684.
60. Patel R.S., Jakymiw A., Yao B., Pauley B.A., Carcamo W.C., Katz J., Cheng J.Q., Chan E.K. High resolution of microRNA signatures in human whole saliva. Arch. Oral Biol. 2011, 56:1506-1513.